WAYNE SANDLER: Open Payments
NPI 1770549388 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 17 payments from 5 companies in 2025. Trend: 2023 $411 · 2024 $538 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Bausch Health US, LLC | 7 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $144 |
| E.R. Squibb & Sons, L.L.C. | 5 | $120 |
| Axsome Therapeutics, Inc. | 3 | $92 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
Products named: APLENZIN, CAPLYTA, Auvelity, REXULTI.
Industry payments across CA — which companies pay providers there.
